349 related articles for article (PubMed ID: 25001132)
41. Influence of endothelin-1 gene polymorphisms on the progression of autosomal dominant polycystic kidney disease.
Reiterová J; Merta M; Stekrová J; Cabartová Z; Cibulka R; Maixnerová D; Rysavá R; Ríhová Z; Tesar V; Motán J
Kidney Blood Press Res; 2006; 29(3):182-8. PubMed ID: 16943682
[TBL] [Abstract][Full Text] [Related]
42. Mechanisms and management of hypertension in autosomal dominant polycystic kidney disease.
Rahbari-Oskoui F; Williams O; Chapman A
Nephrol Dial Transplant; 2014 Dec; 29(12):2194-201. PubMed ID: 24463189
[TBL] [Abstract][Full Text] [Related]
43. The role of the renin-angiotensin-aldosterone system in preeclampsia: genetic polymorphisms and microRNA.
Yang J; Shang J; Zhang S; Li H; Liu H
J Mol Endocrinol; 2013 Apr; 50(2):R53-66. PubMed ID: 23369849
[TBL] [Abstract][Full Text] [Related]
44. Influence of ACE (I/D) and G460W polymorphism of alpha-adducin in autosomal dominant polycystic kidney disease.
Persu A; El-Khattabi O; Messiaen T; Pirson Y; Chauveau D; Devuyst O
Nephrol Dial Transplant; 2003 Oct; 18(10):2032-8. PubMed ID: 13679477
[TBL] [Abstract][Full Text] [Related]
45. [Gene polymorphisms of renin-angiotensin system in patients with kidney diseases].
Narita I; Gejyo F
Nihon Rinsho; 2004 Oct; 62(10):1811-5. PubMed ID: 15500123
[TBL] [Abstract][Full Text] [Related]
46. Effects of endothelial nitric oxide synthase gene on end stage renal disease progression in autosomal dominant polycystic kidney disease.
Xue C; Zhou CC; Sun LJ; He LL; Xu CG; Dai B; Mei CL
Nephrology (Carlton); 2014 Oct; 19(10):630-7. PubMed ID: 24995932
[TBL] [Abstract][Full Text] [Related]
47. A link between the intrarenal renin angiotensin system and hypertension in autosomal dominant polycystic kidney disease.
Kocyigit I; Yilmaz MI; Unal A; Ozturk F; Eroglu E; Yazici C; Orscelik O; Sipahioglu MH; Tokgoz B; Oymak O
Am J Nephrol; 2013; 38(3):218-25. PubMed ID: 23988725
[TBL] [Abstract][Full Text] [Related]
48. Epidermal growth factor receptor polymorphism and autosomal dominant polycystic kidney disease.
Magistroni R; Manfredini P; Furci L; Ligabue G; Martino C; Leonelli M; Scapoli C; Albertazzi A
J Nephrol; 2003; 16(1):110-5. PubMed ID: 12653106
[TBL] [Abstract][Full Text] [Related]
49. Autosomal dominant polycystic kidney disease: role of the renin-angiotensin system in raised blood pressure in progression of renal and cardiovascular disease.
Lawson CR; Doulton TW; MacGregor GA
J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):139-45. PubMed ID: 17094050
[TBL] [Abstract][Full Text] [Related]
50. RAAS polymorphisms alter the acute blood pressure response to aerobic exercise among men with hypertension.
Blanchard BE; Tsongalis GJ; Guidry MA; LaBelle LA; Poulin M; Taylor AL; Maresh CM; Devaney J; Thompson PD; Pescatello LS
Eur J Appl Physiol; 2006 May; 97(1):26-33. PubMed ID: 16468060
[TBL] [Abstract][Full Text] [Related]
51. [Renal manifestation of Autosomal Dominant Polycystic Kidney Disease].
Galliani M; Chicca S; Vitaliano E; Di Lullo L; Giannakakis K; Paone A
G Ital Nefrol; 2018 Mar; 35(2):. PubMed ID: 29582957
[TBL] [Abstract][Full Text] [Related]
52. Nephron-specific expression of components of the renin-angiotensin-aldosterone system in the mouse kidney.
Reinhold SW; Krüger B; Barner C; Zoicas F; Kammerl MC; Hoffmann U; Bergler T; Banas B; Krämer BK
J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):46-55. PubMed ID: 22247339
[TBL] [Abstract][Full Text] [Related]
53. Genetic polymorphisms of renin-angiotensin system and progression of interstitial nephritis.
Buraczyńska M; Grzebalska A; Spasiewicz D; Orłowska G; Ksiazek A
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):330-6. PubMed ID: 12898858
[TBL] [Abstract][Full Text] [Related]
54. Hepatic and renal manifestations in autosomal dominant polycystic kidney disease: a dichotomy of two ends of a spectrum.
van Gulick JJ; Gevers TJ; van Keimpema L; Drenth JP
Neth J Med; 2011 Sep; 69(9):367-71. PubMed ID: 21978978
[TBL] [Abstract][Full Text] [Related]
55. ACE inhibitors, left ventricular mass and renal cyst growth in ADPKD.
Schrier RW
Pharmacol Res; 2016 Dec; 114():166-168. PubMed ID: 27794499
[TBL] [Abstract][Full Text] [Related]
56. Linkage analysis between loci in the renin-angiotensin axis and end-stage renal disease in African Americans.
Yu H; Bowden DW; Spray BJ; Rich SS; Freedman BI
J Am Soc Nephrol; 1996 Dec; 7(12):2559-64. PubMed ID: 8989734
[TBL] [Abstract][Full Text] [Related]
57. Association between polymorphisms in the renin-angiotensin-aldosterone system genes and essential hypertension in the Han Chinese population.
Ji L; Cai X; Zhang L; Fei L; Wang L; Su J; Lazar L; Xu J; Zhang Y
PLoS One; 2013; 8(8):e72701. PubMed ID: 24015270
[TBL] [Abstract][Full Text] [Related]
58. The association of hypertension with renin-angiotensin system gene polymorphisms in the Lebanese population.
Saab YB; Gard PR; Overall AD
J Renin Angiotensin Aldosterone Syst; 2011 Dec; 12(4):588-94. PubMed ID: 21628354
[TBL] [Abstract][Full Text] [Related]
59. Evidence for association of endothelial cell nitric oxide synthase gene polymorphism with earlier progression to end-stage renal disease in a cohort of Hellens from Greece and Cyprus.
Lamnissou K; Zirogiannis P; Trygonis S; Demetriou K; Pierides A; Koptides M; Deltas CC
Genet Test; 2004; 8(3):319-24. PubMed ID: 15727257
[TBL] [Abstract][Full Text] [Related]
60. Variable renal disease progression in autosomal dominant polycystic kidney disease: a role for nitric oxide?
Devuyst O
J Nephrol; 2003; 16(3):449-52. PubMed ID: 12832751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
